Sohaib Mir is a Senior Investment Principal at LifeArc.
Most recently he was an Investment Director with ALSA Ventures, focused on therapeutics investing. Prior to that he was a Principal at Cambridge Innovation Capital and he has also worked at Perella Weinberg Partners.
Sohaib qualified in Medicine at the University of Birmingham where he also completed a PhD in CNS regeneration. He practised medicine at Addenbrooke’s Hospital in Cambridge and gained an MPhil in Bioscience Enterprise from the University of Cambridge.
